Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3738681016 | Brompheniramine and guaifenesin and hydrocodone only product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
3738682011 | Product containing only brompheniramine and guaifenesin and hydrocodone in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form | Has active ingredient | Guaifenesin | true | Inferred relationship | Some | 3 | |
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form | Has active ingredient | Hydrocodone | true | Inferred relationship | Some | 1 | |
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form | Is a | Brompheniramine and guaifenesin and hydrocodone only product | true | Inferred relationship | Some | ||
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form | Has active ingredient | Brompheniramine | true | Inferred relationship | Some | 2 | |
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form | Is a | Brompheniramine- and guaifenesin- and hydrocodone-containing product in oral dose form | true | Inferred relationship | Some | ||
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form | Plays role | Expectorant therapeutic role | true | Inferred relationship | Some | ||
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form | Plays role | Antitussive therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution | Is a | True | Brompheniramine and guaifenesin and hydrocodone only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets